Elliott Management has built a significant position in life-science tools supplier Bio-Rad Laboratories. The activist investor has not yet disclosed the exact size of the stake or its specific strategic intentions.
Bio-Rad currently holds an estimated 33% stake in German lab-equipment supplier Sartorius AG. Elliott Management also maintains an existing investment in Sartorius.
This dual positioning creates a complex dynamic between the parent investor and the underlying company. These overlapping stakes may form a key part of Elliott’s strategic plan.